Mohamed W Attwa

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 71

Top Topics

Liquid Chromatography

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Molecules (Basel, Switzerland)

Drug design, development and therapy

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ziyad Binkhathlan, Raisuddin Ali, Osman Yusuf, Abdullah H Alomrani, Mohamed M Badran, Abdullah K Alshememry, Aws Alshamsan, Faleh Alqahtani, Wajhul Qamar, Mohamed W Attwa
Polycaprolactone-Vitamin E TPGS Micellar Formulation for Oral Delivery of Paclitaxel. Polymers 16 (15) (2024)
Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Ion Trap LC/MS reveals the generation of reactive intermediates in acalabrutinib metabolism: phase I metabolic profiling and bioactivation pathways elucidation. RSC advances 14 (23) (2024)
Ziyad Binkhathlan, Raisuddin Ali, Osman Yusuf, Abdullah H Alomrani, Mohamed M Badran, Abdullah K Alshememry, Aws Alshamsan, Faleh Alqahtani, Wajhul Qamar, Mohamed W Attwa
Polycaprolactone-Vitamin E TPGS Micellar Formulation for Oral Delivery of Paclitaxel. Polymers 16 (15) (2024)
Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Ion Trap LC/MS reveals the generation of reactive intermediates in acalabrutinib metabolism: phase I metabolic profiling and bioactivation pathways elucidation. RSC advances 14 (23) (2024)
Mohamed W Attwa, A F M Motiur Rahman
Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation. Molecules (Basel, Switzerland) 28 (4) (2023)
Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Investigation of Fenebrutinib Metabolism and Bioactivation Using MS 3 Methodology in Ion Trap LC/MS. Molecules (Basel, Switzerland) 28 (10) (2023)
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, Manal A El-Gendy, Adel S El-Azab, Yousef A Bin Jardan, Ali A El-Gamal
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi
Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes. Molecules (Basel, Switzerland) 28 (5) (2023)
Ehab M Elzayat, Abdelrahman Y Sherif, Fahd A Nasr, Mohamed W Attwa, Doaa H Alshora, Sheikh Fayaz Ahmad, Ali S Alqahtani
Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles. Materials (Basel, Switzerland) 16 (15) (2023)
Awadh M Ali, A F M Motiur Rahman, Mohamed W Attwa, Hany W Darwish
Selective Stability Indicating Liquid Chromatographic Method Based on Quality by Design Framework and In Silico Toxicity Assessment for Infigratinib and Its Degradation Products. Molecules (Basel, Switzerland) 28 (22) (2023)
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, Manal A El-Gendy, Adel S El-Azab, Yousef A Bin Jardan, Ali A El-Gamal
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi
Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, A F M Motiur Rahman
Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation. Molecules (Basel, Switzerland) 28 (4) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Wajid Rehman, Aneela Maalik, Urooba Gulshan, Mohamed W Attwa, Hany W Darwish, Hazem A Ghabbour, Nawab Ali
Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer's Candidates. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, Manal A El-Gendy, Adel S El-Azab, Yousef A Bin Jardan, Ali A El-Gamal
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Haitham Alrabiah, Essam A Ali, Rashad A Alsalahi, Mohamed W Attwa, Gamal A E Mostafa
Fabrication and Applications of Potentiometric Membrane Sensors Based on γ-Cyclodextrin and Calixarene as Ionophores for the Determination of a Histamine H1-Receptor Antagonist: Fexofenadine. Polymers 15 (13) (2023)
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, Manal A El-Gendy, Adel S El-Azab, Yousef A Bin Jardan, Ali A El-Gamal
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohamed W Attwa, A F M Motiur Rahman
Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation. Molecules (Basel, Switzerland) 28 (4) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Wajid Rehman, Aneela Maalik, Urooba Gulshan, Mohamed W Attwa, Hany W Darwish, Hazem A Ghabbour, Nawab Ali
Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer's Candidates. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Aneela Maalik, Wajid Rehman, Mohamed W Attwa, Rafia Masood, Hany W Darwish, Hazem A Ghabbour
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Gamal A E Mostafa, Maha F El-Tohamy, Essam A Ali, Rashad Al-Salahi, Mohamed W Attwa, Haitham AlRabiah
Ionophore-Based Polymeric Sensors for Potentiometric Assay of the Anticancer Drug Gemcitabine in Pharmaceutical Formulation: A Comparative Study. Molecules (Basel, Switzerland) 28 (22) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Ahmed H Bakheit, Adnan A Kadi
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method. Molecules (Basel, Switzerland) 28 (6) (2023)
Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi
Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes. Molecules (Basel, Switzerland) 28 (5) (2023)
Ibrahim A Darwish, Nourah Z Alzoman, Aliyah Almomen, Abdulrahman A Al-Mehizia, Mohamed W Attwa, Hany W Darwish, Ahmed Y Sayed
Development and validation of an UPLC-ESI-MS/MS method for quantification of duvelisib in plasma: application to pharmacokinetic study in rats. RSC advances 13 (12) (2023)
Mohamed W Attwa, A F M Motiur Rahman
Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Ahmed H Bakheit, Adnan A Kadi
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method. Molecules (Basel, Switzerland) 28 (6) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Ahmed H Bakheit, Adnan A Kadi
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method. Molecules (Basel, Switzerland) 28 (6) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Aneela Maalik, Wajid Rehman, Mohamed W Attwa, Rafia Masood, Hany W Darwish, Hazem A Ghabbour
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Ibrahim A Darwish, Nourah Z Alzoman, Aliyah Almomen, Abdulrahman A Al-Mehizia, Mohamed W Attwa, Hany W Darwish, Ahmed Y Sayed
Development and validation of an UPLC-ESI-MS/MS method for quantification of duvelisib in plasma: application to pharmacokinetic study in rats. RSC advances 13 (12) (2023)
Mohamed W Attwa, A F M Motiur Rahman
Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening. Pharmaceutics 15 (10) (2023)
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, Manal A El-Gendy, Adel S El-Azab, Yousef A Bin Jardan, Ali A El-Gamal
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohamed W Attwa, Ahmed H Bakheit, Ali Saber Abdelhameed, Adnan A Kadi
An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib. Molecules (Basel, Switzerland) 28 (20) (2023)
Mohamed W Attwa, Ali Saber Abdelhameed, Nawaf A Alsaif, Adnan A Kadi, Haitham AlRabiah
A validated LC-MS/MS analytical method for the quantification of pemigatinib: metabolic stability evaluation in human liver microsomes. RSC advances 12 (31) (2022)
Nasser S Al-Shakliah, Adnan A Kadi, Haya I Aljohar, Haitham AlRabiah, Mohamed W Attwa
Profiling of in vivo , in vitro and reactive zorifertinib metabolites using liquid chromatography ion trap mass spectrometry. RSC advances 12 (32) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
A F M Motiur Rahman, Ahmad J Obaidullah, Mohamed W Attwa
A Novel Green Micellar HPLC-UV Method for the Estimation of Vandetanib in Pure Form, Human Urine, Human Plasma and Human Liver Microsomes Matrices with Application to Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 27 (24) (2022)
A F M Motiur Rahman, Ahmad J Obaidullah, Mohamed W Attwa
A Novel Green Micellar HPLC-UV Method for the Estimation of Vandetanib in Pure Form, Human Urine, Human Plasma and Human Liver Microsomes Matrices with Application to Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 27 (24) (2022)
A F M Motiur Rahman, Ahmad J Obaidullah, Mohamed W Attwa
A Novel Green Micellar HPLC-UV Method for the Estimation of Vandetanib in Pure Form, Human Urine, Human Plasma and Human Liver Microsomes Matrices with Application to Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
A F M Motiur Rahman, Ahmad J Obaidullah, Mohamed W Attwa
A Novel Green Micellar HPLC-UV Method for the Estimation of Vandetanib in Pure Form, Human Urine, Human Plasma and Human Liver Microsomes Matrices with Application to Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Mohamed W Attwa, Hany W Darwish, Nasser S Al-Shakliah, Adnan A Kadi
A Validated LC-MS/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): Metabolic Stability Estimation. Molecules (Basel, Switzerland) 26 (9) (2021)
Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation. Drug design, development and therapy 15 (2021)
Haitham AlRabiah, Adnan A Kadi, Haya I Aljohar, Mohamed W Attwa, Nasser S Al-Shakliah, Sabry M Attia, Gamal A E Mostafa
A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma. Drug design, development and therapy 14 (2020)
Mohamed W Attwa, Adnan A Kadi, Ali Saber Abdelhameed
Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites. RSC advances 10 (9) (2020)
Mohamed W Attwa, Adnan A Kadi, Ali Saber Abdelhameed, Hassan A Alhazmi
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies. Drug design, development and therapy 14 (2020)
Mohamed W Attwa, Ali Saber Abdelhameed, Nasser S Al-Shakliah, Adnan A Kadi
LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay. Drug design, development and therapy 14 (2020)
Nasser S Al-Shakliah, Mohamed W Attwa, Adnan A Kadi, Haitham AlRabiah
Identification and characterization of in silico , in vivo , in vitro , and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites. RSC advances 10 (28) (2020)
Ali Saber Abdelhameed, Mohamed W Attwa, Adnan A Kadi
Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach. Drug design, development and therapy 14 (2020)
Thamer A Alsubi, Mohamed W Attwa, Ahmed H Bakheit, Hany W Darwish, Hatem A Abuelizz, Adnan A Kadi
In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling. RSC advances 10 (38) (2020)
Ali Alhoshani, Fawaz E Alanazi, Moureq R Alotaibi, Mohamed W Attwa, Adnan A Kadi, Abdullah Aldhfyan, Sabah Akhtar, Shireen Hourani, Abdelali Agouni, Asad Zeidan, Hesham Mohamed Korashy
EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation: In Vivo and in Vitro Rat Studies. Chemical research in toxicology 33 (7) (2020)
Mohamed W Attwa, Adnan A Kadi, Hany W Darwish
Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry. Drug design, development and therapy 14 (2020)
Haitham Alrabiah, Adnan A Kadi, Mohamed W Attwa, Ali Saber Abdelhameed
A simple liquid chromatography-tandem mass spectrometry method to accurately determine the novel third-generation EGFR-TKI naquotinib with its applicability to metabolic stability assessment. RSC advances 9 (9) (2019)
Haitham AlRabiah, Adnan A Kadi, Mohamed W Attwa, Ali Saber Abdelhameed, Gamal A E Mostafa
Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profiling. RSC advances 9 (11) (2019)
Ali S Abdelhameed, Mohamed W Attwa, Nasser S Al-Shaklia, Adnan A Kadi
A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation. Royal Society open science 6 (6) (2019)
Mohamed W Attwa, Adnan A Kadi, Ali S Abdelhameed
Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways. Journal of separation science 43 (4) (2019)
Mohamed W Attwa, Adnan A Kadi, Haitham AlRabiah, Hany W Darwish
Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling. RSC advances 9 (18) (2019)
Ali S Abdelhameed, Mohamed W Attwa, Adnan A Kadi
Liquid chromatography-tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites. Royal Society open science 6 (8) (2019)
Ali S Abdelhameed, Adnan A Kadi, Mohamed W Attwa, Haitham AlRabiah
Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability. PloS one 14 (4) (2019)
Mohamed W Attwa, Adnan A Kadi
Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS. RSC advances 9 (57) (2019)
Adnan A Kadi, Hany W Darwish, Hatem A Abuelizz, Thamer A Alsubi, Mohamed W Attwa
Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC-MS/MS: in vitro metabolic investigation. Royal Society open science 6 (1) (2019)
Mohammed M Alanazi, Hamad M Al Kahtani, Abdulrahman A Al-Mehizia, Mohamed W Attwa, Ahmed H Bakheit, Hany W Darwish
Validated liquid chromatography tandem mass spectrometry for simultaneous quantification of foretinib and lapatinib, and application to metabolic stability investigation. RSC advances 9 (34) (2019)
Mohamed W Attwa, Adnan A Kadi, Ali S Abdelhameed
Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS: in vitro phase I metabolic investigation. RSC advances 8 (68) (2018)
Mohamed W Attwa, Adnan A Kadi, Hany W Darwish, Ali S Abdelhameed
Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasma. RSC advances 8 (70) (2018)
Mohamed W Attwa, Adnan A Kadi, Hany W Darwish, Sawsan M Amer, Haitham Alrabiah
A reliable and stable method for the determination of foretinib in human plasma by LC-MS/MS: Application to metabolic stability investigation and excretion rate. European journal of mass spectrometry (Chichester, England) 24 (4) (2018)
Adnan A Kadi, Mohamed W Attwa, Hany W Darwish
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways. RSC advances 8 (3) (2018)